Acute Respiratory Distress Syndrome (ARDS): Mechanism

1. Triggers and Initiating Insults

2. Phase Structure of ARDS

Harrison's Principles of Internal Medicine - ARDS phase progression

3. The Exudative Phase (Days 0-7): Core Pathogenic Mechanism

3a. Alveolar-Capillary Barrier Disruption

• Endothelial injury: inflammatory signals (e.g., LPS, TNF-alpha, IL-1beta) cause endothelial cell activation, retraction of tight junctions, and increased paracellular permeability. Loss of endothelial barrier integrity is both necessary and sufficient for ARDS development.
• Epithelial injury: Type I pneumocytes (which cover ~95% of alveolar surface) are particularly vulnerable. Their death occurs via necrosis, apoptosis, mechanical stretch, and coagulation-mediated pathways. Type II pneumocytes are more resistant but are also damaged.

3b. The Central Role of Neutrophils

1. Recruitment: Alveolar macrophages sense the initial insult (PAMPs, DAMPs) and release chemokines including IL-8 (CXCL8), TNF-alpha, and IL-1beta, which recruit circulating neutrophils into the pulmonary vasculature and alveoli.
2. Sequestration: Neutrophils become sequestered in pulmonary capillaries partly because their large diameter relative to capillary diameter forces them to deform, slowing transit; inflammatory signals further promote adhesion via endothelial ICAM-1 and E-selectin upregulation.
3. Tissue destruction: Activated neutrophils release a destructive arsenal:
   • Proteases (elastase, matrix metalloproteinases) - degrade extracellular matrix and surfactant protein A
   • Reactive oxygen species (ROS) - directly damage epithelial and endothelial cell membranes
   • Myeloperoxidase - generates hypochlorous acid
   • Neutrophil extracellular traps (NETs) - also implicated in vascular injury
4. These products together cause the epithelial necrosis and endothelial permeability increase that define DAD. - Robbins & Kumar Basic Pathology; Murray & Nadel's

3c. Macrophage-Driven Cytokine Storm

• They release TNF-alpha, IL-1beta, IL-6, IL-8, platelet-activating factor (PAF), and complement fragments
• These cytokines perpetuate neutrophil recruitment and activate the coagulation cascade
• IL-6 in particular contributes to diffuse alveolar damage and multi-organ dysfunction - Schwartz's Principles of Surgery; Murray & Nadel's

3d. Coagulation and Fibrin Deposition

• Endothelial injury exposes subendothelial collagen, activating the extrinsic coagulation cascade
• Alveolar macrophages express tissue factor, further driving fibrin generation
• Simultaneously, fibrinolysis is suppressed (elevated PAI-1 levels), shifting the balance toward clot formation
• Intravascular fibrin microthrombi form in pulmonary capillaries, contributing to pulmonary hypertension and dead space
• Intra-alveolar fibrin combines with cellular debris to form the characteristic hyaline membranes - Murray & Nadel's; Goldman-Cecil

3e. Surfactant Dysfunction

• Damaged type II cells produce less surfactant
• Neutrophil elastase degrades surfactant protein A, a key component
• Plasma proteins leaking into the airspace inhibit surfactant function
• The ratio of large (active) to small (inactive) surfactant aggregates falls
• The net result is increased alveolar surface tension, predisposing to widespread alveolar collapse (atelectasis) and worsening V/Q mismatch - Murray & Nadel's

3f. Physiologic Consequences of the Exudative Phase

• Hypoxemia: from right-to-left shunt (perfused but non-ventilated flooded alveoli) and V/Q mismatch
• Decreased lung compliance: fluid-filled, collapsed alveoli are stiff
• Increased dead space: pulmonary microvascular thrombosis eliminates gas exchange in some regions
• Pulmonary hypertension: from hypoxic vasoconstriction, fibrin microthrombi, and vascular compression by PEEP
• Increased minute ventilation: respiratory compensation leads to rapid shallow breathing

4. The Proliferative Phase (Days 7-21)

• Type II pneumocyte hyperplasia: surviving type II cells proliferate to re-epithelialize denuded alveolar surfaces, then differentiate into type I cells
• Interstitial inflammation: fibroblasts infiltrate, beginning collagen deposition
• Hyaline membrane organization: fibrin matrices are remodeled
• Decreased neutrophils: the acute inflammatory burden diminishes
• Most patients show gradual improvement in oxygenation during this phase - Harrison's Principles

5. The Fibrotic Phase (Day 21+)

• Progressive pulmonary fibrosis: collagen deposition in alveolar walls and interstitium
• Bullae formation, obliteration of pulmonary capillaries
• Sustained hypoxemia and ventilator dependence
• Fibroproliferation may begin very early - elevated N-terminal procollagen peptide III (a marker of collagen synthesis) can be detected in BAL fluid within 24 hours of ARDS onset - Murray & Nadel's

6. Ventilator-Induced Lung Injury (VILI) - A Secondary Mechanism

• Volutrauma: large tidal volumes overdistend non-injured lung units (ARDS creates heterogeneous disease, so a tidal volume meant for the whole lung goes preferentially to the "baby lung" of relatively normal alveoli)
• Atelectrauma: repetitive opening and closing of collapsed alveoli generates shear forces at the interface of collapsed and aerated tissue
• Biotrauma: mechanical stretch itself releases cytokines (IL-8, IL-6, TNF-alpha) from alveolar cells, creating a positive feedback loop that can injure distal organs

7. Angiopoietin Signaling

• Angiopoietin-1 (Ang1): enhances endothelial barrier integrity via the Tie2 receptor
• Angiopoietin-2 (Ang2): a competitive antagonist that destabilizes the endothelial barrier and promotes vascular leak
• In ARDS and sepsis, Ang2 levels are markedly elevated, contributing to sustained permeability
• Genetic variants in the Ang2 gene are associated with higher plasma Ang2 and increased ARDS risk - Murray & Nadel's

8. Genetic and Subphenotype Determinants

• Hyperinflammatory phenotype: high IL-8, IL-6, TNF receptor-1, low protein C - worse mortality, more vasopressor-dependent shock
• Hypo-inflammatory phenotype: milder inflammatory burden, better prognosis

Summary Diagram of Core Mechanism

Initiating insult (sepsis, pneumonia, trauma, aspiration)
            ↓
Alveolar macrophage activation
            ↓
Cytokine release (TNF-α, IL-1β, IL-6, IL-8, PAF)
            ↓
Neutrophil recruitment & sequestration in alveoli
            ↓
Neutrophil products: proteases, ROS, NETs
            ↓
Type I pneumocyte + endothelial cell injury/death
            ↓
Alveolar-capillary barrier breakdown
            ↓
Protein-rich exudate floods alveoli (DAD + hyaline membranes)
            ↓
Surfactant dysfunction → alveolar collapse
Coagulation activation → microthrombi → dead space
            ↓
Hypoxemia (shunt + V/Q mismatch) + decreased compliance
            ↓
RESPIRATORY FAILURE